Cart
sales@molnova.com
AMRI-59
CAS No. 923515-92-8
AMRI-59( AMRI 59 | AMRI59 )
Catalog No. M27848 CAS No. 923515-92-8
AMRI-59 is a potent inhibitor of PrxI with anti-tumor activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 393 | Get Quote |
|
| 10MG | 581 | Get Quote |
|
| 25MG | 888 | Get Quote |
|
| 50MG | 1242 | Get Quote |
|
| 100MG | 1674 | Get Quote |
|
| 500MG | 3348 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAMRI-59
-
NoteResearch use only, not for human use.
-
Brief DescriptionAMRI-59 is a potent inhibitor of PrxI with anti-tumor activity.
-
DescriptionAMRI-59 is a potent inhibitor of PrxI with anti-tumor activity.
-
In Vitro——
-
In Vivo——
-
SynonymsAMRI 59 | AMRI59
-
PathwayOthers
-
TargetOther Targets
-
RecptorLPA1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number923515-92-8
-
Formula Weight401.51
-
Molecular FormulaC25H27N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(=O)c1cccc(NC(=O)N2CCC(Cc3ccc(cc3)-n3cccc3)CC2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jonathan Ellery, et al. Identification of compounds acting as negative allosteric modulators of the LPA 1 receptor. Eur J Pharmacol. 2018 Aug 15;833:8-15.
molnova catalog
related products
-
Pep 2-8
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor. Potent inhibitor of PCSK9 binding to LDL receptor (IC50 = 0.8 μM). Restores LDL uptake in HepG2 cells treated with PCSK9.
-
DPPS
DPPS (12-Dipalmitoyl-sn-glycero-3-PS sodium salt) is an anionic diacyl-phospholipid, a form of phosphatidylserine (PS), which is a negatively charged phospholipid located in the lobules of cell membranes. DPPS are used to make cationic vesicles and liposomes.
-
Chromocarbe
Chromocarb is a vascular protective agent used in the treatment of venous disorders and microvascular affections.
